Results 211 to 216 of about 55,815 (216)

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

Journal of Hepatology, 2017
Josep M Llovet, Ann-Lii Cheng, Jordi Bruix   +2 more
exaly  

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat

International Journal of Pharmaceutics, 2011
Qiang Zhang, Xue-Qing Wang
exaly  

Sorafenib

Reactions Weekly
openaire   +2 more sources

Sorafenib

Reactions Weekly, 2011
openaire   +2 more sources

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

Annals of Oncology
Yoon-Koo Kang, B Sangro
exaly  

Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy

Autophagy
, Yanqiong Zhang, Lingxiang Yu
exaly